H1B Salary Data

Home › Employers › Regeneron Pharmaceuticals, Inc. › Principal Statistical Programmer

Principal Statistical Programmer at Regeneron Pharmaceuticals, Inc.: H-1B salaries

15 labor condition applications for the job title Principal Statistical Programmer at Regeneron Pharmaceuticals, Inc.. Median offered base salary $150,000; middle half $139,530–$154,938.

Applications (LCAs)15
Median offered salary$150,000
Middle half of salaries$139,530–$154,938
10th–90th percentile$136,094–$156,349

By fiscal year

Fiscal yearLCAsMedian salary
FY20232$140,016
FY20242$136,875
FY20254$147,774
FY20267$154,875

Applications

Base salaryLocationSubmittedStart dateStatus
$155,000
Level II
Warren, NJMay 7, 2026Jun 1, 2026Certified
$160,038
Level II
Tarrytown, NYJan 30, 2026Jul 30, 2026Certified
$154,875
Level II
Tarrytown, NYJan 30, 2026Jul 30, 2026Certified
$151,458
Level III
Warren, NJJan 23, 2026Jul 20, 2026Certified
$157,248
Level II
Tarrytown, NYJan 23, 2026Jul 19, 2026Certified
$152,500
Level II
Warren, NJJan 12, 2026Jul 10, 2026Certified
$135,000–$150,000
Level II
Warren, NJJan 12, 2026Feb 2, 2026Certified
$145,548
Level III
Warren, NJSep 17, 2025Mar 18, 2026Certified
$137,734
Level II
Basking Ridge, NJJan 7, 2025Jun 3, 2025Certified
$150,000
Level II
Tarrytown, NYNov 9, 2024Nov 25, 2024Certified
$155,000
Level III
Tarrytown, NYOct 22, 2024Dec 2, 2024Certified
$134,689
Level II
Belmont, MAMay 10, 2024May 27, 2024Certified
$139,061
Level III
Basking Ridge, NJJan 23, 2024May 24, 2024Certified
$140,000
Level II
Basking Ridge, NJAug 9, 2023Aug 17, 2023Certified
$140,032
Level III
Basking Ridge, NJJun 13, 2023Nov 24, 2023Certified

Principal Statistical Programmer at all employers →

Other jobs at Regeneron Pharmaceuticals, Inc.

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).